N
Niina Saarinen
Researcher at University of Turku
Publications - 60
Citations - 2356
Niina Saarinen is an academic researcher from University of Turku. The author has contributed to research in topics: Enterolactone & Hydroxymatairesinol. The author has an hindex of 25, co-authored 59 publications receiving 2092 citations. Previous affiliations of Niina Saarinen include Linköping University.
Papers
More filters
Journal ArticleDOI
Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products
TL;DR: It is argued that a network pharmacology approach would enable an effective mapping of the yet unexplored target space of natural products, hence providing a systematic means to extend the druggable space of proteins implicated in various complex diseases.
Journal ArticleDOI
Hydroxymatairesinol, a novel enterolactone precursor with antitumor properties from coniferous tree (Picea abies).
Niina Saarinen,Anni Wärri,Sari Mäkelä,Christer Eckerman,M. Reunanen,M. Ahotupa,S. M. Salmi,A. A. Franke,L. Kangas,Risto Santti +9 more
TL;DR: HMR, the most abundant single component of spruce lignans, was metabolized to enterolactone (ENL) as the major metabolite in rats after oral administration and was an effective antioxidant in vitro.
Journal ArticleDOI
Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase.
Xiangdong Li,Elina Nokkala,Wei Yan,Tomi Streng,Niina Saarinen,Anni Wärri,Ilpo Huhtaniemi,Risto Santti,Sari Mäkelä,Sari Mäkelä,Matti Poutanen +10 more
TL;DR: The AROM(+) mouse model provides a novel tool to investigate the consequences of a prolonged increase in conversion of androgens to estrogens which results in complex hormonal disturbances altering the structure and function of various male reproductive organs.
Journal ArticleDOI
The role of early life genistein exposures in modifying breast cancer risk
TL;DR: It is proposed that the effects on mammary gland morphology and signalling pathways induced by pubertal exposure to genistein mimic those induced by the oestrogenic environment of early first pregnancy.
Journal ArticleDOI
Role of dietary lignans in the reduction of breast cancer risk.
TL;DR: Administration of plant lignans which are further metabolized to ENL, or ENL as such, have been shown to inhibit or delay the growth of experimental mammary cancer, generating interest in the use of lignan as components of breast cancer risk reducing functional foods.